KELLI GRAMBEAU: Open Payments
NPI 1306468483 · COEUR D ALENE, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$72 in 3 payments from 3 companies in 2025. Trend: 2023 $76 · 2024 $47 · 2025 $72
Food & beverage: $72
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 1 | $31 |
| ABBVIE INC. | 1 | $26 |
| Sumitomo Pharma America, Inc. | 1 | $15 |
Products named: LEQVIO, QULIPTA, GEMTESA.
Industry payments across ID — which companies pay providers there.
